台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
  • 股價
    41.60
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    247
  • 產業
    上櫃 生技醫療類股
  • 155人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生華科 (6492)籌碼相關-凱基-站前 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-站前 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/12/15241.2800.0041.6025900.34%
2025/11/26541.8400.0041.5056320.79%
2025/11/1300.00444.3044.50-4618-0.65%
2025/11/10442.33342.3041.0516100.16%
2025/11/07545.05546.5044.8505890.00%
2025/11/06145.60546.4746.25-4582-0.69%
2025/11/05146.50347.4246.60-2580-0.34%
2025/11/03145.6000.0045.7515610.18%
2025/10/30146.20046.7045.2015520.18%
2025/10/291444.91245.5344.50125372.23%
2025/10/2700.00447.5647.80-4517-0.77%
2025/10/23549.42549.0348.6005000.00%
2025/10/22150.70250.3848.10-1467-0.21%
2025/10/2149.351.436850.9151.60-18.7436-4.28%
2025/10/20348.25048.2548.2533610.83%
2025/10/1700.00142.1543.90-1353-0.28%
2025/10/16239.60340.3039.95-1336-0.30%
2025/10/150.237.9000.0037.500.23250.06%
2025/10/140.138.40138.3537.50-0.9327-0.27%
2025/10/090.138.0000.0038.800.13300.03%
2025/10/08138.8000.0038.7013270.31%
2025/09/3000.00141.0541.05-1303-0.33%
2025/09/2600.00141.3041.30-1298-0.34%
2025/09/22140.20240.2039.20-1286-0.35%
2025/09/19240.65239.8839.9002760.00%
2025/09/18237.9500.0037.7022820.71%
2025/09/1700.00739.4539.45-7259-2.70%
2025/09/16135.8000.0035.9012540.39%
2025/09/15236.0000.0036.1022520.79%
2025/09/11436.9000.0036.6042521.59%
2025/09/1000.00338.2038.00-3247-1.21%
2025/08/22137.0000.0036.8012220.45%
2025/08/11235.4500.0035.5522440.82%
2025/08/0800.00136.7036.40-1248-0.40%
2025/07/290.235.2000.0035.200.22330.09%
2025/07/24635.66336.2035.1532311.30%
2025/07/210.134.4000.0034.050.12210.05%
2025/07/180.134.5000.0034.550.12200.05%
2025/07/1700.00135.4535.15-1217-0.46%
2025/07/16134.3000.0034.4512110.47%
2025/07/1100.00532.9633.15-5205-2.43%
2025/07/1000.00132.5032.45-1206-0.49%
2025/06/271537.911236.1736.6032241.34%
2025/06/2000.00532.6532.95-5192-2.59%
2025/06/13235.9800.0034.5021951.02%
2025/06/12636.21236.1535.6041912.09%
2025/05/27134.1000.0033.9511800.55%
2025/05/2100.00535.0034.65-5184-2.71%
2025/05/20837.14435.5135.2541832.18%
2025/05/16434.25334.2033.6511620.62%
2025/05/1200.00133.2533.10-1159-0.63%
2025/05/09133.6000.0033.1011590.63%
2025/05/06232.2500.0032.1021631.22%
2025/04/14132.4000.0032.7511800.55%
2025/04/08132.0000.0031.6011650.61%
2025/04/071035.1000.0035.10101536.52%
2025/03/31039.2500.0038.1001610.00%
2025/03/25341.6500.0041.5531492.00%
2025/03/17042.1000.0042.2501490.00%
2025/03/14043.6000.0042.4001480.00%
2025/03/0600.00144.1044.30-1149-0.67%
2025/03/05044.8300.0044.8001500.00%
2025/03/03045.9000.0044.6001530.00%
2025/02/26045.6500.0045.8001500.00%
2025/02/24146.05146.3045.8501560.00%
2025/02/1800.00444.2544.25-4158-2.52%
2025/02/1700.00244.5544.75-2162-1.23%
2025/02/10143.9000.0043.7511790.56%
2025/02/04043.3000.0042.8001980.00%
2025/01/2000.00241.6041.65-2378-0.53%
2025/01/150.142.3000.0042.150.13810.03%
2025/01/07043.6400.0042.8003890.00%
2024/12/31242.9000.0043.5024100.49%
〈熱門股〉Google AI模型研究成果點名生華科新藥 周漲逾1成Anue鉅亨-2025/10/18
生華科CX-5641治療MYC異常淋巴瘤 核准進入第1b/2期臨床試驗Anue鉅亨-2025/09/05
生華科 相關文章
生華科 相關影音